DrugPatentWatch Database Preview

Details for Patent: 6,978,945

Email this page to a colleague

« Back to Dashboard

Which drugs does patent 6,978,945 protect, and when does it expire?

Patent 6,978,945 protects EVAMIST and is included in one NDA.

This patent has seventeen patent family members in ten countries.

Summary for Patent: 6,978,945

Title:	Dispensing device
Abstract:	Hand-held dispensing devices for dispensing and applying a substance to the skin of a host are described. The devices include a hollow body, a capsule mounted within the hollow body for containing the substance, a nozzle mounted within the hollow body communicating with the substance in the capsule, an actuator to cause metered quantities of the substance to be dispensed from the capsule through the nozzle, a shroud defining an exit space for receiving the substance emerging from the nozzle, and a cap detachably mounted on the shroud to selectively open and close the nozzle and thereby control escape of the substance from the capsule.
Inventor(s):	Wong; Kon Euan (Glen Waverly, AU), Bayly; Mark Simon (Eltham North, AU)
Assignee:	Acrux DDS Pty Ltd (AU)
Application Number:	10/442,323
Patent Claim Types: see list of patent claims	Dosage form; Device; Composition; Formulation;

Drugs Protected by US Patent 6,978,945

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Padagis Us	EVAMIST	estradiol	SPRAY;TRANSDERMAL	022014-001	Jul 27, 2007		RX	Yes	Yes			Y

Foreign Priority and PCT Information for Patent: 6,978,945

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Australia	PR1845	Dec 01, 2000

International Family Members for US Patent 6,978,945

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2002220352
Australia	2005234689
Australia	2035202